PPARGC1A and neoplasm: Bezafibrate, a PGC1α agonist, has been shown to boost antitumor immunity via upregulating mitochondrial OXPHOS and inhibition of apoptosis in MC38-bearing mouse tumor model treated with PD1 blockade (77).